Sildenafil Prevents and Reverses Transverse-Tubule Remodeling and Ca 2+ Handling Dysfunction in Right Ventricle Failure Induced by Pulmonary Artery Hypertension
- 1 February 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 59 (2), 355-362
- https://doi.org/10.1161/hypertensionaha.111.180968
Abstract
Right ventricular (RV) failure (RVF) is the main cause of death in patients with pulmonary artery hypertension (PAH). Sildenafil, a phosphodiesterase type 5 inhibitor, was approved recently for treatment of PAH patients. However, the mechanisms underlying RV contractile malfunction and the benefits of sildenafil on RV function are not well understood. We aimed to investigate the following: (1) the ultrastructural and excitation-contraction coupling alterations underlying PAH-induced RVF; (2) whether the ultrastructural changes are reversible; and (3) the mechanisms underlying the therapeutic benefits of sildenafil in PAH-RVF. We used a single injection of monocrotaline in Wistar rats to induce pulmonary vascular proliferation, which led to PAH and RVF. RV myocytes displayed severe transverse (T)-tubule loss and disorganization, as well as blunted and dys-synchronous sarcoplasmic reticulum Ca 2+ release. Sildenafil prevented and reversed the monocrotaline-induced PAH and LV filling impairment. Early intervention with sildenafil prevented RV hypertrophy and the development of RVF, T-tubule remodeling, and Ca 2+ handling dysfunction. Although late treatment with sildenafil did not reverse RV hypertrophy in animals with established RVF, RV systolic function was improved. Furthermore, late intervention partially reversed both the impairment of myocyte T-tubule integrity and Ca 2+ handling protein and sarcoplasmic reticulum Ca 2+ release function in monocrotaline-treated rats. In conclusion, PAH-induced increase in RV afterload causes severe T-tubule remodeling and Ca 2+ handling dysfunction in RV myocytes, leading to RV contractile failure. Sildenafil prevents and partially reverses ultrastructural, molecular, and functional remodeling of failing RV myocytes. Reversal of pathological T-tubule remodeling, although incomplete, is achievable without the regression of RV hypertrophy.Keywords
This publication has 29 references indexed in Scilit:
- Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in MiceCirculation, 2011
- Right Ventricular Failure: A Novel Era of Targeted TherapyCurrent Heart Failure Reports, 2010
- T-Tubule Remodeling During Transition From Hypertrophy to Heart FailureCirculation Research, 2010
- Prolonged mechanical unloading affects cardiomyocyte excitation‐contraction coupling, transverse‐tubule structure, and the cell surfaceThe FASEB Journal, 2010
- Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophyNature Medicine, 2005
- Right Ventricular Myocardium Derives From the Anterior Heart FieldCirculation Research, 2004
- Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in RatsAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failureCardiovascular Research, 2003
- Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failureCardiovascular Research, 2001
- The Pressure-Overloaded Right Ventricle in Pulmonary HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1998